China Sky One Medical, Inc. Obtains Production Rights For Two New Drugs

China Sky One Medical, Inc., , a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced recently that its subsidiary, Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang"), successfully obtained production approval from the State Food and Drug Administration (SFDA) in China for two of its newly developed drugs.

Tinea Liniment is a traditional Chinese medicine intended for the treatment of athlete's foot (tinea pedis), hand ringworm (tinea manus), jock itch (tinea cruris) and fungal skin infection (tinea versicolor). These fungal infections are difficult to cure and new outbreaks occur frequently. Compared to existing products, Tinea Liniment has been shown to be more effective in treating these infections with lower recurrence, making it competitive in the market for these products.

Skincare Cream is a traditional Chinese medicine intended for the treatment of skin diseases such as acne, bottle nose, chromophytosis and vitiligo. There are currently few similar TCM products on the market.

"These new drugs address a number of relatively common diseases in China and we are excited to receive production approval from the SFDA," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "Our marketing team is currently examining the market potential for these drugs, which we believe is very large, as we continue to pursue our strategy of winning market share by expanding our product mix."

About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Company Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit: http://www.skyonemedical.com/ .

SOURCE: China Sky One Medical, Inc.